Putamen function and MAOA genotype define genetic and neural subtypes of hyperactivity-impulsivity in ADHD
Journal of Affective Disorders · 2026-11 · 412 · 122127
DOI: 10.1016/j.jad.2026.122127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026-11. Verfasst von Yuan Feng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Cli…. Hauptthemen laut MEDLINE: Monoamine Oxidase, Attention Deficit Disorder with Hyperactivity, Putamen, Impulsive Behavior. Die Arbeit nennt 66 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND Hyperactivity-impulsivity (HI) is a core ADHD symptom associated with the monoamine oxidase A (MAOA) gene. The neurobiological mechanisms underlying HI heterogeneity in children carrying the MAOA risk genotype remain unclear and may involve distinct subtypes. METHODS A total of 326 children with ADHD were genotyped for MAOA, including 108 non-risk and 218 risk carriers. Semi-supervised clustering of HI and executive function (EF) scores from the ADHD Rating Scale, Conners' Rating Scale, and BRIEF was used to classify MAOA risk carriers into subtypes, with non-risk patients as the reference. fALFF differences across subtypes, cognitive mediation between brain activity and behavior, and treatment response at follow-up were examined. RESULTS Two subtypes were identified among MAOA risk carriers. Compared with the non-risk group, Subtype 1 showed elevated HI and impaired EF, whereas Subtype 2 showed preserved EF and no HI elevation. Subtype 1 had increased fALFF in the inferior temporal gyrus and higher putamen fALFF than Subtype 2, while Subtype 2 showed increased fALFF in the angular gyrus relative to the non-risk group. Putamen fALFF was associated with inhibition, shifting, emotional control, and the Behavioral Regulation Index (BRI), and mediation analysis suggested an indirect effect on HI via the BRI. After 4 weeks of medication, Subtype 2 showed greater improvement in conduct problems and anxiety. CONCLUSION Putamen function may underlie HI heterogeneity among MAOA risk carriers and was associated with better EF, milder symptoms, and greater treatment response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Ho…
- State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Feng, Y., Gao, Y., Liu, Q., Zhu, Y., Dang, C., Wu, G., Zhong, S., Shi, N., Lin, X., Zhu, Z., Ju, C., Zhang, H., Sui, J., Liu, L., & Sun, L. (2026). Putamen function and MAOA genotype define genetic and neural subtypes of hyperactivity-impulsivity in ADHD. Journal of Affective Disorders, 412, 122127. https://doi.org/10.1016/j.jad.2026.122127
Vancouver
Feng Y, Gao Y, Liu Q, Zhu Y, Dang C, Wu G, et al. Putamen function and MAOA genotype define genetic and neural subtypes of hyperactivity-impulsivity in ADHD. Journal of Affective Disorders. 2026;412:122127. doi:10.1016/j.jad.2026.122127
BibTeX
@article{Feng2026,
author = {Feng, Yuan and Gao, Yuan and Liu, Qianrong and Zhu, Yu and Dang, Chen and Wu, Guisen and Zhong, Shaogen and Shi, Naizhen and Lin, Xindi and Zhu, Ziqing and Ju, Changxi and Zhang, Huiyi and Sui, Jing and Liu, Lu and Sun, Li},
title = {Putamen function and MAOA genotype define genetic and neural subtypes of hyperactivity-impulsivity in ADHD},
journal = {Journal of Affective Disorders},
year = {2026},
volume = {412},
pages = {122127},
doi = {10.1016/j.jad.2026.122127}
}
EUVIMED